Weight Loss

What Happens When You Stop a GLP-1?

Stopping a GLP-1 like Ozempic often leads to appetite return and weight regain. Here is what the research shows and how to plan for stopping safely.

Reviewed by Dr. Jason Saylor, DO Last reviewed 2026-06-02 4 min read

Quick answer

When you stop a GLP-1 medication like Ozempic, Wegovy, Mounjaro, or Zepbound, the appetite suppression it provided fades, and many people regain a significant portion of the weight they lost. This is because GLP-1 medications manage the biology of appetite while you take them; they do not permanently reset it. Studies have shown notable weight regain in the year after stopping. That does not mean you must take them forever, but it does mean stopping should be planned with a clinician, not done abruptly. These are prescription medications requiring physician supervision, and individual results vary.

Why Do People Regain Weight After Stopping a GLP-1?

People regain weight because GLP-1 medications work by actively suppressing appetite and slowing digestion, and those effects stop when the drug leaves the body. The underlying biology that drove weight gain, including hunger signals and how the body defends a higher weight, was managed by the medication, not eliminated. So when you stop, appetite tends to return, often noticeably, and many people eat more and regain weight. This is a physiological response, not a lack of willpower.

Understanding this reframes the medication accurately: it is more like ongoing treatment for a chronic condition than a short course that fixes things permanently. That is an honest and important distinction, because it shapes how you plan, what you expect, and how you talk with your prescriber about the long term. For how the appetite effects work in the first place, see our guide on how GLP-1 medications work.

How Much Weight Do People Regain?

Research on stopping semaglutide has shown that, on average, people regained a large share of the weight they had lost in the year or so after discontinuation, along with a partial reversal of some metabolic improvements. The exact amount varies widely by person and by what they do after stopping, particularly whether they maintain the nutrition and activity changes built during treatment. Some people hold more of their loss; others regain most of it.

The honest takeaway is that regain is common and expected without a maintenance plan, not a guaranteed total reversal or a sign the drug "didn't work." Results during treatment were real; they just depend on the treatment continuing or on a deliberate strategy to maintain them. This is why a supervised program plans for what comes after the active weight-loss phase.

Can You Stop a GLP-1 Without Regaining Weight?

It is possible to limit regain, but it takes a deliberate plan, and results still vary. Strategies include building strong nutrition and activity habits during treatment so they persist, preserving muscle through adequate protein and resistance training, and sometimes tapering or transitioning rather than stopping cold, all guided by a clinician. Some people stay on a maintenance dose long term specifically to hold their results, which is a legitimate medical approach for a chronic condition.

There is no method that guarantees zero regain, and anyone promising that is overselling. The realistic goal is to maximize what you keep through preparation and supervision. For protecting muscle, which matters for metabolism and maintenance, see our guide on protein and muscle on GLP-1s. Ascend's medical weight loss program plans for maintenance, not just the loss phase.

Should You Ever Stop a GLP-1?

Sometimes stopping is appropriate, and it is a decision made with a clinician, not unilaterally. Reasons to stop or pause can include side effects that are not manageable, pregnancy or planning pregnancy, cost or access issues, reaching and stabilizing at a goal with a solid maintenance plan, or a change in medical circumstances. What matters is that the decision weighs the likely regain against the reason for stopping, and that there is a plan for what happens next.

Stopping abruptly without a plan is what tends to lead to fast, frustrating regain. If cost or access is the reason, it is worth exploring options with a prescriber before stopping outright, including coverage, savings programs, and alternatives. The goal is an intentional decision with support, not a quiet quit.

Care at Ascend: Learn more about Weight Loss at Ascend Mind and Body, or book an appointment.

Frequently asked questions

How quickly does weight come back after stopping Ozempic?

Appetite often returns within weeks of stopping, and weight regain typically follows over the months after that. Studies measured significant regain over roughly a year. The pace and amount vary by person and depend heavily on whether nutrition and activity habits are maintained. A planned approach with a clinician slows and reduces regain.

Is it bad to stop and restart a GLP-1?

Restarting is common and can be done, but it is a prescriber's decision, and restarting usually means re-titrating from a lower dose to manage side effects rather than jumping back to your previous dose. Cycling on and off without a plan can be frustrating and harder on tolerability. Talk to your clinician before stopping if you anticipate restarting.

Do I need to keep seeing a prescriber in Florida if I stay on a GLP-1 long term?

Yes. Long-term GLP-1 use requires ongoing physician supervision in Florida and everywhere, including periodic follow-up, lab monitoring, and dose review. This is true whether care is in person or by telehealth. A maintenance plan is part of responsible long-term treatment, not optional.

Can I get help tapering off a GLP-1 by telehealth in Florida?

Often, yes. Florida law allows licensed clinicians to manage follow-up care, including planning a taper or maintenance strategy, by telehealth when it meets the standard of care. A supervised plan reduces the regain that comes with abrupt stopping. Ascend offers this kind of supervised follow-up as part of its weight-loss program.

Medically reviewed by

Dr. Jason Saylor, DO

View clinician profile · Last reviewed 2026-06-02

This article is for general educational purposes only and is not medical advice. It does not create a provider-patient relationship. Talk with a qualified Florida-licensed clinician about your individual situation.

Sources

  1. Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism. 2022. (Indexed at PubMed, ncbi.nlm.nih.gov.)
  2. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Prescription Medications to Treat Overweight and Obesity. niddk.nih.gov.
  3. U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information. accessdata.fda.gov.

Ready to Take the Next Step?

Schedule your appointment today. Same-day virtual visits available.

Book Appointment

Or call (813) 670-3005